In the wake of a recent safety scare in a confirmatory trial of its antibody-drug conjugate Zynlonta, ADC Therapeutics is tightening its belt in an effort to get the most out of its cancer med. On ...

For all its benefits, the modern digital world can be quite a grind. Endless notifications, subscription everything, devices that always need recharging -- it can be a lot. What if you could go back ...

CHICAGO -- Treatment with investigational izalontamab brengitecan (iza-bren) significantly improved progression-free survival (PFS) and overall survival (OS) in patients with unresectable locally ...

It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

Development and evaluation of a novel digital pathology image analysis pipeline for prediction of clinical outcomes with the TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan ...

Antibody-drug conjugates (ADCs) have emerged as one of the most impactful therapeutic advances in modern oncology, fundamentally reshaping the treatment landscape across both hematologic malignancies ...

Daiichi Sankyo is poised to report significantly lower full-year profit for fiscal year 2025, primarily due to a 95 billion Japanese yen ($610 million) hit linked to its precautionary antibody-drug ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with type 2 diabetes who use GLP-1 analogs ...

ADCs have transformed metastatic breast cancer care. How do you see their role evolving in earlier-stage TNBC and HR+ breast cancer? ADCs have been remarkably effective therapies and are moving ...

Harnessing heat generated by a device itself, microscopic silicon structures could lead to more energy-efficient thermal sensing and signal processing. Heat generated by electronic devices is usually ...

Today's crop of luxury cars represents some of the most modern and technologically advanced vehicles on the road. That includes some of the most powerful luxury cars coming in 2026, and beyond. But as ...

Adults whose type 2 diabetes was treated with GLP-1 receptor agonists were more likely to develop cognitive impairment over 10 years than their counterparts not treated with GLP-1 agents, a propensity ...